Delivery Order SPE2DB22D1202-SPE2DB25FVHG9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,260.98 to AmerisourceBergen Drug Corp for Eohilia 2 mg/10 ml stick pack pharmaceutical product, with an ultimate completion date of August 11, 2025. This competitive delivery order, utilizing firm fixed pricing, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $14,411.01 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eohilia 2 mg/10 mL stick pack units. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a $13,537.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for EOHILIA 2 mg/10 ml stick pack pharmaceutical products. The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, carries no set-aside designation and was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,420.67 by the Defense Logistics Agency for the supply of Eohilia 2 mg/10 ml stick pack medication. The contract, executed on July 18, 2025, with an ultimate completion date of July 21, 2025, was issued on a firm fixed-price basis with no set-aside designation, indicating competitive award. Performance will be completed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,260.98 to AmerisourceBergen Drug Corp for Eohilia 2 mg/10 ml stick pack pharmaceutical supplies on August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and calls for delivery to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. The delivery order is executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,673.47 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eohilia 2 mg/10 ml stick pack medication. The contract represents a firm fixed-price delivery order with a completion date of July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is issued under AmerisourceBergen...
- This federal contract award, valued at $3,225.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EOHILIA 2 MG/10 ML STICK PACK 10ML, a pharmaceutical product, with an ultimate completion date of May 8, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type, and there is no set-aside designation, indicating open competition....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $10,298.10 firm fixed-price delivery order is for the supply of EOHILIA 2 MG/10 ML STICK PACK 10ML pharmaceutical products. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,386.95 delivery order contract is for the supply of EOHILIA 2 MG/10 ML STICK PACK 10ML medical products. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,260.98, is for the delivery of medical products including the pharmaceutical item "EOHILIA 2 MG/10 ML STICK PACK 10ML." The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVHG9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,782.94 to AmerisourceBergen Drug Corp for Eohilia 2 mg/10 ml stick pack pharmaceutical product on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The contract carries no set-aside designation and was competitively awarded through open procurement. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as a primary supplier to military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio of federal contracts demonstrates consistent capability to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, generic and brand-name drugs, and medical devices across multiple therapeutic domains. This specific delivery order reflects the company's ongoing role in supporting the Department of Defense's pharmaceutical supply requirements through the DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/13/25 |